Skip to main content

Unable to load price data. Sorry.


SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN.DL)

CAPS Rating: No stars

A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:SCLN.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Nightshaded (< 20)
Submitted May 13, 2011

This biotech, I mean volcano, is beginning to smoke. First I highly recommend doing YOUR OWN research, I can't express this enough. Do not base your decisions from what myself or some total stranger claims, which could be tainted with hidden motives… More

zzlangerhans (98.69)
Submitted May 11, 2011

Seems like SciClone's share price keeps gravitating back up towards 5, despite unpredictability of future revenues due to an ongoing review of Zadaxin pricing by Chinese authorities, coincident investigations of the company by the SEC and US DOJ, and… More


  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about SCLN.DL.

No one has written a Pitch for SCLN.DL stock yet. Tell us why you think SCLN.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in SCLN.DL.

No players have picked SCLN.DL yet. Tell us why you think SCLN.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SCLN.DL.